Endeavor

Moffitt Study Explores Key Risk Factors To Better Personalize CAR T-Cell Therapy

The study analyzed ide-cel to help physicians intervene and reduce toxicities in multiple myeloma patients

Largest Comprehensive Study Compares Efficacy of CAR T Products for Multiple Myeloma

Cilta-cel demonstrates greater effectiveness than ide-cel but carries higher toxicities, study finds

Radiation Therapy May Boost Effectiveness of CAR T-Cell Treatment in Aggressive Multiple Myeloma

Moffitt study highlights the potential for improved outcomes by targeting extramedullary disease before cell therapy

Patti Scialfa, Wife and Bandmate of Bruce Springsteen, Reveals Multiple Myeloma Diagnosis

Learn what Moffitt is doing to advance new therapies for this rare blood cancer

Weight Loss Drugs Linked to Reduced Cancer Risk, Study Shows

People treated with GLP-1 drugs were less likely to be diagnosed with 10 of the 13 obesity-associated cancers

FDA Set to Approve Earlier Use of CAR T for Multiple Myeloma

The treatment is currently approved for patients who fail four lines of treatment

Is Outpatient CAR T Therapy Safe for Multiple Myeloma Patients?

Outpatient treatment significantly reduced average hospital stay to four days, study shows

Victory Over Adversity

Bucs equipment director claims victory over a formidable opponent: cancer

Spreading the Warmth of Holiday Cheer

For more than a decade, Moffitt’s Patient and Family Advisory Program has delivered blankets to patients on Christmas Eve